Effectiveness of nirsevimab reimmunization against RSV hospitalization during the second season in high-risk children

Clicks: 22
ID: 329676
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #38 of 145 articles by views in journal of the pediatric infectious diseases society

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 145 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Summary Results suggest a moderate effectiveness of reimmunization with a second nirsevimab dose against hospitalization for respiratory syncytial virus infection during the second season in high-risk children, although the estimated effectiveness was highly uncertain (42%; 95% confidence interval: −25% to 73%).
Reference Key
openalex_W7214217688 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Susana Monge, Olivier G. Nunez, Roberto Pastor‐Barriuso
Journal journal of the pediatric infectious diseases society
Year 2026
DOI
10.1093/jpids/piag104
URL
https://doi.org/10.1093/jpids/piag104
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.